Cognifisense
7 employees on LinkedIn · 2 known investors
CognifiSense develops Virtual Reality Neuropsychological Therapy (VRNT), an immersive VR program that retrains the brain's pain pathways to reduce chronic pain without medication or invasive treatments. It serves patients experiencing chronic pain and the healthcare providers who treat them.
Founders & leadership
TB
Tassilo BaeuerleinCo-Founder & Executive Chairman
Investors · 2
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Cognifisense do?
- CognifiSense develops Virtual Reality Neuropsychological Therapy (VRNT), an immersive VR program that retrains the brain's pain pathways to reduce chronic pain without medication or invasive treatments. It serves patients experiencing chronic pain and the healthcare providers who treat them.
- Who founded Cognifisense?
- Cognifisense was founded by Tassilo Baeuerle.
- Who are Cognifisense's investors?
- Cognifisense's investors include Bantam Group, Joyance Partners.